Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Oral Cavity Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02775370
What this trial is testing

Apatinib in Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck

Who this might be right for
Adenoid Cystic Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 68
Early research (Phase 1)Study completedNCT00014456
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerCarcinoma of Unknown Primary+9 more
Dartmouth-Hitchcock Medical Center 35
Not applicableStudy completedNCT00899769
What this trial is testing

Biomarkers in Patients With Head and Neck Cancer and in Healthy Volunteers

Who this might be right for
Head and Neck Cancer
Vanderbilt University Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT00004865
What this trial is testing

Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy

Who this might be right for
Head and Neck Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07634601
What this trial is testing

Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer

Who this might be right for
Advanced Endometrial CarcinomaMetastatic Endometrial CarcinomaRecurrent Endometrial Carcinoma+2 more
Jonsson Comprehensive Cancer Center 50
Large-scale testing (Phase 3)Study completedNCT00293462
What this trial is testing

GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerMucositis OralRadiation Toxicity+1 more
Marilyn Dodd 91
Large-scale testing (Phase 3)Study completedNCT00090337
What this trial is testing

Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer

Who this might be right for
Head and Neck CancerPain
Memorial Sloan Kettering Cancer Center 73
Not applicableStudy completedNCT00896675
What this trial is testing

Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 352
Testing effectiveness (Phase 2)Study completedNCT00748358
What this trial is testing

An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate Cancer

Who this might be right for
Prostatic NeoplasmsNeoplasms, Hormone-DependentTumor Markers, Biological+2 more
Assistance Publique - Hôpitaux de Paris 50
Testing effectiveness (Phase 2)Ended earlyNCT00646659
What this trial is testing

Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery

Who this might be right for
Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC 47
Not applicableEnded earlyNCT00898742
What this trial is testing

Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 58
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Not applicableLooking for participantsNCT04534127
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 56
Testing effectiveness (Phase 2)Study completedNCT00005035
What this trial is testing

Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Ohio State University Comprehensive Cancer Center
Not applicableEnded earlyNCT00898430
What this trial is testing

Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 49
Large-scale testing (Phase 3)Study completedNCT00003576
What this trial is testing

Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery

Who this might be right for
Head and Neck Cancer
National Cancer Centre, Singapore 200
Testing effectiveness (Phase 2)Study completedNCT00003582
What this trial is testing

Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer

Who this might be right for
Carcinoma of Unknown PrimaryHead and Neck Cancer
University of Miami 36
Testing effectiveness (Phase 2)Looking for participantsNCT05136196
What this trial is testing

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+22 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00098631
What this trial is testing

Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Squamous Cell Carcinoma of the Hypopharynx+13 more
National Cancer Institute (NCI) 88
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Next Page
150